Nitric oxide impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases

Molecular Biology of the Cell

Volumn 14, Issue 8, 2003, Pages 3470-3481

  Metzen, Eric ^a   Zhou, Jie ^a   Jelkmann, Wolfgang ^a   Fandrey, Joachim ^a   Brüne, Bernhard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1; NITRIC OXIDE; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; S NITROSOGLUTATHIONE; SYNTHETIC PEPTIDE; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CELL LINE; CHEMICAL REACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROXYLATION; HYPOXIA; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; UBIQUITINATION;

EID: 0042469448     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E02-12-0791     Document Type: Article

References (60)

1. 2+ of extradiol dioxygenases. J. Biol. Chem. 260, 14035-14044.
2. Bruick, R.K., and McKnight, S.L. (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
3. Brüne, B., Mohr, S., and Messmer, U.K. (1996). Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Rev. Physiol. Biochem. Pharmacol. 127, 1-30.
4. Brüne, B., and Zhou, J. (2003). The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Curr. Med. Chem. 10, 845-855.
5. Chan, D.A., Sutphin, P.D., Denko, N.C., and Giaccia, A.J. (2002). Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 277, 40112-40117.
6. 2 sensing. J. Biol. Chem. 275, 25130-25138.
7. Clifford, S.C., Cockman, M.E., Smallwood, A.C., Mole, D.R., Woodward, E.R., Maxwell, P.H., Ratcliffe, P.J., and Maher, E.R. (2001). Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. Hum. Mol. Genet. 10, 1029-1038.
8. Cockman, M.E. et al. (2000). Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733-25741.
9. Epstein, A.C. et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
10. Fandrey, J., Frede, S., and Jelkmann, W. (1994). Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem. J. 303, 507-510.
11. Grisham, M.B., Jourd'Heuil, D., and Wink, D.A. (1999). Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276, G315-321.
12. Hart, T.W. (1997). Some observation concerning the S-nitroso and S-phenylsulfonyl derivatives of L-cysteine and glutathione. Tetrahedron Lett. 26, 2013-2016.
13. Hegg, E.L., and Que, L., Jr. (1997). The 2-His-1-carboxylate facial triad - an emerging structural motif in mononuclear non-heme iron(II) enzymes. Eur. J. Biochem. 250, 625-629.
14. Hellwig-Bürgel, T., Rutkowski, K., Metzen, E., Fandrey, J., and Jelkmann, W. (1999). Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561-1567.
15. Hewitson, K.S. et al. (2002). Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351-26355.
16. Hon, W.C. et al. (2002). Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 417, 975-978.
17. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95, 7987-7992.
18. Huang, L.E., Willmore, W.G., Gu, J., Goldberg, M.A., and Bunn, H.F. (1999). Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. J. Biol. Chem. 274, 9038-9044.
19. Isaacs, J.S., Jung, Y.J., Mimnaugh, E.G., Martinez, A., Cuttitta, F., and Neckers, L.M. (2002). Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J. Biol. Chem. 277, 29936-29944.
20. Ivan, M. et al. (2002). Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99, 13459-13464.
21. Ivan, M., and Kaelin, W.G., Jr. (2001). The von Hippel-Lindau tumor suppressor protein. Curr. Opin. Genet. Dev. 11, 27-34.
22. 2 sensing. Science 292, 464-468.
23. 2-regulated prolyl hydroxylation. Science 292, 468-472.
24. Kaelin, W.G., Jr. (2002). How oxygen makes its presence felt. Genes Dev. 16, 1441-1445.
25. Kallio, P.J., Wilson, W.J., O'Brien, S., Makino, Y., and Poellinger, L. (1999). Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525.
26. Karni, R., Dor, Y., Keshet, E., Meyuhas, O., and Levitzki, A. (2002). Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1alpha expression under normoxia. J. Biol. Chem. 277, 42919-42925.
27. Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D'Acquisto, F., Addeo, R., Makuuchi, M., and Esumi, H. (2000). Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95, 189-197.
28. Kimura, H., Weisz, A., Ogura, T., Hitomi, Y., Kurashima, Y., Hashimoto, K., D'Acquisto, F., Makuuchi, M., and Esumi, H. (2001). Identification of hypoxia-inducible factor I ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J. Biol. Chem. 276, 2292-2298.
29. Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., and Plate, K.H. (2000). Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19, 5435-5443.
30. Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L., and Bruick, R.K. (2002a). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
31. Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J., and Whitelaw, M.L. (2002b). Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858-861.
32. Lee, D.H., and Goldberg, A.L. (1998). Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8, 397-403.
33. Liu, Y., Christou, H., Morita, T., Laughner, E., Semenza, G.L., and Kourembanas, S. (1998). Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J. Biol. Chem. 273, 15257-15262.
34. Mahon, P.C., Hirota, K., and Semenza, G.L. (2001). FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686.
35. Masson, N., Willam, C., Maxwell, P.H., Pugh, C.W., and Ratcliffe, P.J. (2001). Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206.
36. Maxwell, P.H., Pugh, C.W., and Ratcliffe, P.J. (2001). The pVHL-hIF-1 system. A key mediator of oxygen homeostasis. Adv. Exp. Med. Biol. 502, 365-376.
37. Maxwell, P.H. et al. (1999). The tumour suppressor protein VHL targets hypoxia-inducible facto4rs for oxygen-dependent proteolysis. Nat. Lett. 399, 271-275.
38. Min, J.H., Yang, H., Ivan, M., Gertler, F., Kaelin, W.G., Jr., and Pavletich, N.P. (2002). Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886-1889.
39. Oehme, F., Ellinghaus, P., Kolkhof, P., Smith, T.J., Ramakrishnan, S., Hutter, J., Schramm, M., and Flamme, I. (2002). Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296, 343-349.
40. Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., Huang, L.E., Pavletich, N., Chau, V., and Kaelin, W.G. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423-427.
41. O'Rourke, J.F., Tian, Y.M., Ratcliffe, P.J., and Pugh, C.W. (1999). Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha. J. Biol. Chem. 274, 2060-2071.
42. Palmer, L.A., Gaston, B., and Johns, R.A. (2000). Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol. Pharm. 58, 1197-1203.
43. Roach, P.L., Clifton, I.J., Fulop, V., Harlos, K., Barton, G.J., Hajdu, J., Andersson, I., Schofield, C.J., and Baldwin, J.E. (1995). Crystal structure of isopenicillin N synthase is the first from a new structural family of enzymes. Nature 375, 700-704.
44. Salceda, S., and Caro, J. (1997). Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J. Biol. Chem. 272, 22642-22647.
45. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
46. Sandau, K.B., Fandrey, J., and Brune, B. (2001a). Accumulation of HIF-1alpha under the influence of nitric oxide. Blood 97, 1009-1015.
47. Sandau, K.B., Faus, H.G., and Brune, B. (2000). Induction of hypoxia-inducible-factor I by nitric oxide is mediated via the PI 3K pathway. Biochem. Biophys. Res. Commun. 278, 263-267.
48. Sandau, K.B., Zhou, J., Kietzmann, T., and Brune, B. (2001b). Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276, 39805-39811.
49. Semenza, G.L. (2001). Hif-1, O(2), and the 3 phds. How animal cells signal hypoxia to the nucleus. Cell 107, 1-3.
50. Semenza, G.L. (2002). HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8, S62-67.
51. Sogawa, K., Numayama-Tsuruta, K., Ema, M., Abe, M., Abe, H., and Fujii-Kuriyama, Y. (1998). Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc. Natl. Acad. Sci. USA 95, 7368-7373.
52. Stamler, J.S., Singel, D.J., and Loscalzo, J. (1992). Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898-1902.
53. Tanimoto, K., Makino, Y., Pereira, T., and Poellinger, L. (2000). Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19, 4298-4309.
54. Vaux, E.C., Metzen, E., Yeates, K.M., and Ratcliffe, P.J. (2001). Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood 98, 296-302.
55. Wang, F., Sekine, H., Kikuchi, Y., Takasaki, C., Miura, C., Heiwa, O., Shuin, T., Fujii-Kuriyama, Y., and Sogawa, K. (2002). HIF-1alpha-prolyl hydroxylase: molecular target of nitric oxide in the hypoxic signal transduction pathway. Biochem. Biophys. Res. Commun. 295, 657-662.
56. Wang, G.L., and Semenza, G.L. (1995). Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237.
57. 2-regulated gene expression. FASEB J. 16, 1151-1162.
58. Yu, F., White, S.B., Zhao, Q., and Lee, F.S. (2001). HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98, 9630-9635.
59. Zhou, J., Fandrey, J., Schumann, J., Tiegs, G., and Brune, B. (2003). NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells. Am. J. Physiol. Cell Physiol. 284, C439-C446.
60. Zhu, H., Jackson, T., and Bunn, H.F. (2002). Detecting and responding to hypoxia. Nephrol. Dial. Transplant 17(Suppl 1), 3-7.